View in EDS

Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?

Saved in:

Bibliographic Details
Title:	Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
Authors:	Di Marco L; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Valerio F; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Maculan Y; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Medici B; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Spallanzani A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Dominici M; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Ricci AD; Medical Oncology Unit, National Institute of Gastroenterology, IRCCS 'S. de Bellis' Research Hospital, Castellana Grotte, Italy., Rizzo A; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Salati M; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.
Source:	Expert opinion on biological therapy [Expert Opin Biol Ther] 2026 Mar; Vol. 26 (3), pp. 257-267. Date of Electronic Publication: 2026 Mar 11.
Publication Type:	Journal Article; Review
Journal Info:	Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1744-7682
DOI:	10.1080/14712598.2026.2642273